Ventana Medical Systems, Inc. Sustainability Profile
Ventana Medical Systems, Inc., a subsidiary of Roche, is a leading player in the global diagnostics industry, headquartered in the United States. Founded in 1985, the company has established itself as a pioneer in the development of advanced tissue-based diagnostic solutions, particularly in the field of oncology. With a strong presence in North America and Europe, Ventana is renowned for its innovative automated staining systems and companion diagnostics, which enhance the accuracy and efficiency of cancer diagnosis. The company’s commitment to quality and precision has positioned it as a trusted partner for laboratories and healthcare providers worldwide. Notable achievements include the introduction of groundbreaking technologies that streamline laboratory workflows and improve patient outcomes, solidifying Ventana's reputation as a leader in the medical diagnostics sector.
DitchCarbon Score
How does Ventana Medical Systems, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Ventana Medical Systems, Inc.'s score of 83 is higher than 89% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Ventana Medical Systems, Inc., headquartered in the US, currently does not report specific carbon emissions data, as indicated by the absence of emissions figures. However, the company is part of a corporate family that includes Roche Holding AG, from which it inherits climate commitments and performance metrics. Roche Holding AG has established significant climate initiatives, including Science Based Targets Initiative (SBTi) commitments and participation in the Carbon Disclosure Project (CDP). These initiatives aim to reduce greenhouse gas emissions across various scopes, although specific reduction targets for Ventana Medical Systems, Inc. have not been detailed. As a current subsidiary of Roche, Ventana Medical Systems aligns with the broader sustainability goals set by its parent company, which focuses on reducing emissions and enhancing environmental responsibility. While specific emissions data for Ventana is not available, the company's commitment to climate action is supported by the initiatives and performance metrics cascaded from Roche Holding AG.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 403,136,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | - | - | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | 188,924,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 00,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 |
How Carbon Intensive is Ventana Medical Systems, Inc.'s Industry?
How Carbon Intensive is Ventana Medical Systems, Inc.'s Location?
Ventana Medical Systems, Inc.'s Scope 3 Categories Breakdown
Ventana Medical Systems, Inc.'s Scope 3 emissions, which decreased by 8% last year and increased significantly since 2013, demonstrating supply chain emissions tracking. Nearly all of their carbon footprint comes from suppliers and value chain emissions, representing nearly all emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 71% of Scope 3 emissions.
Top Scope 3 Categories
Ventana Medical Systems, Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Ventana Medical Systems, Inc. has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
